Neubauwohnung Via Aurelia Da 308

DOMUS AURELIAE - In the splendid Aurelio neighborhood, on Via Aurelia at the height of Ergife, we offer for sale an apartment in a building under construction with delivery in December 2027. The building is arranged over seven floors above ground plus a garage and cellars on the S1 floor. The project involves the construction of a building where the dialogue between materials and geometries generates a strong architectural character. Isotex construction system that guarantees solidity, thermal and acoustic insulation, and seismic resistance, thus creating high energy performance buildings. The apartment, located on the 5th floor, consists of a living room with dining area, open kitchen with large openings towards the outside that favor natural light and ventilation, a master bedroom with generous spaces, a second versatile and functional room, perfect as a children’s bedroom or as a private study for smart working, and two bathrooms. The property is completed by a large balcony of about 44 sqm. Parquet flooring for interiors or porcelain stoneware, home automation system, video intercom, integrated central vacuum system, private gym. Possibility to purchase a garage and cellar. Domus Aureliae: an evolved and contemporary idea of home, where every detail is designed to offer well-being, functionality, and authentic comfort. For information, contact Rezza Real Estate Spa Piazza di Spagna 32 Rome Tel. 06 474951. The confidentiality of information imposes professional seriousness in behaviors, so any details will be communicated only to direct interested parties by appointment. There is no intention to collaborate with intermediaries or representatives of unknown third parties. The information provided has no contractual content. The dimensions in terms of volumes and commercial square meters are purely indicative. The data regarding commercial information related to the published listings comes directly from the real estate agency from the respective mediation assignments. Rezza disclaims any responsibility for the presence of any erroneous indications.